[Federal Register Volume 85, Number 75 (Friday, April 17, 2020)]
[Notices]
[Pages 21445-21446]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08167]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2020-N-0907]


Medical Device User Fee Amendments for Fiscal Years 2023 Through 
2027; Public Meeting; Request for Comments; Postponement

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public meeting; postponed.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that the 
public meeting entitled ``Medical Device User Fee Amendments for Fiscal 
Years 2023 Through 2027; Public Meeting; Request for Comments'' that 
was scheduled in the Federal Register on April 3, 2020, to take place 
on May 5, 2020, is postponed until further notice.

DATES: The public meeting will be rescheduled for a future date. 
Information about the rescheduled meeting will be provided when 
available. Submit either electronic or written comments on the medical 
device user fee program and suggestions regarding the commitments FDA 
should propose for the next reauthorized program.

FOR FURTHER INFORMATION CONTACT: Ellen Olson, Center for Devices and 
Radiological Health, Food and Drug Administration, Bldg. 66, Rm. 1664, 
10903 New Hampshire Ave., Silver Spring, MD 20993, 301-796-4322, 
ellen.olson@fda.hhs.gov or 0f4c4b5d4722405f4a5e225c7b7d6e7b6a68666c4661667b666e7b66796a7c4f696b6e2167677c21686079.

SUPPLEMENTARY INFORMATION: The public meeting entitled ``Medical Device 
User Fee Amendments for Fiscal Years 2023 Through 2027; Public Meeting; 
Request for Comments'' was originally announced in the Federal Register 
of March 6, 2020 (85 FR 13165), and was initially scheduled for April 
7, 2020. On April 3, 2020, the meeting was postponed to May 5, 2020, 
and was planned to take place by webcast only due to extenuating 
circumstances (85 FR 18992). FDA continues to evaluate whether and how 
to proceed with upcoming scheduled meetings while our day-to-day 
operations are impacted by the COVID-19 public health emergency, and we 
have decided to

[[Page 21446]]

postpone this public meeting until further notice. Information on the 
rescheduled meeting will be provided in the future when available. The 
web page for the ``Medical Device User Fee Amendments for Fiscal Years 
2023 Through 2027; Public Meeting'' is available at https://www.fda.gov/medical-devices/workshops-conferences-medical-devices/2020-medical-device-meetings-and-workshops. Interested persons may continue 
to submit comments on the medical device user fee program and 
suggestions regarding the commitments FDA should propose for the next 
reauthorized program to the public docket.

    Dated: April 14, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020-08167 Filed 4-16-20; 8:45 am]
BILLING CODE 4164-01-P